APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Infective Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Infective Vaccines Industry Growth and Trends Forecast to 2032

20 December 2025118 pages

Choose your research edition.

Industry ResearchAnti-Infective Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Infective Vaccines Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-Infective Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Infective Vaccines Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Infective Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Anti-Infective Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Infective Vaccines include Sanofi Pasteur, Novartis Vaccines, Merck & Co., GlaxoSmithKline Biologicals, Wyeth Pharmaceuticals, Inc., Protein Sciences Co., Organon Teknika Co., MedImmune LLC and MassBiologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Infective Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Infective Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Infective Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Infective Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Infective Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Infective Vaccines Market by Company

Sanofi Pasteur

Novartis Vaccines

Merck & Co.

GlaxoSmithKline Biologicals

Wyeth Pharmaceuticals, Inc.

Protein Sciences Co.

Organon Teknika Co.

MedImmune LLC

MassBiologics

Intercell Biomedical

ID Biomedical Co.

Emergent BioDefense Operations Lansing Inc.

Diagnostics Ltd.

CSL Ltd.

Berna Biotech

Barr Labs, Inc.

Anti-Infective Vaccines Segment by Type

Inactivated Vaccines

Live/attenuated Vaccines

Conjugate Vaccines

Anti-Infective Vaccines Segment by Application

Bacterial Diseases

Viral Diseases

Anti-Infective Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infective Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Infective Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infective Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Infective Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Infective Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Vaccines Table 2. Major Company of Live/attenuated Vaccines Table 3. Major Company of Conjugate Vaccines Table 4. Global Anti-Infective Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 6. Global Anti-Infective Vaccines Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anti-Infective Vaccines Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anti-Infective Vaccines Sales Market Share in Value by Type (2021-2026) Table 9. Global Anti-Infective Vaccines Price by Type (2021-2026) & (US$/unit) Table 10. Global Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 11. Global Anti-Infective Vaccines Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anti-Infective Vaccines Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anti-Infective Vaccines Sales Market Share in Value by Type (2027-2032) Table 14. Global Anti-Infective Vaccines Price by Type (2027-2032) & (US$/unit) Table 15. North America Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 16. North America Anti-Infective Vaccines Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 18. Europe Anti-Infective Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Anti-Infective Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 22. Latin America Anti-Infective Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Anti-Infective Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Anti-Infective Vaccines Industry Trends Table 26. Anti-Infective Vaccines Industry Drivers Table 27. Anti-Infective Vaccines Industry Opportunities and Challenges Table 28. Anti-Infective Vaccines Industry Restraints Table 29. Global Anti-Infective Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anti-Infective Vaccines Revenue Market Share by Company (2021-2026) Table 31. Global Anti-Infective Vaccines Sales by Company (2021-2026) & (k units) Table 32. Global Anti-Infective Vaccines Sales Share by Company (2021-2026) Table 33. Global Anti-Infective Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Anti-Infective Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anti-Infective Vaccines Major Company Production Sites and Headquarters Table 36. Global Anti-Infective Vaccines Company, Product Type & Application Table 37. Global Anti-Infective Vaccines Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anti-Infective Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anti-Infective Vaccines Sales by Region (2021-2026) & (k units) Table 42. Global Anti-Infective Vaccines Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anti-Infective Vaccines Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anti-Infective Vaccines Sales Market Share in Value by Region (2021-2026) Table 45. Global Anti-Infective Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Anti-Infective Vaccines Sales by Region (2027-2032) & (k units) Table 47. Global Anti-Infective Vaccines Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anti-Infective Vaccines Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anti-Infective Vaccines Sales Market Share in Value by Region (2027-2032) Table 50. Global Anti-Infective Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Anti-Infective Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 53. Global Anti-Infective Vaccines Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anti-Infective Vaccines Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anti-Infective Vaccines Sales Market Share in Value by Application (2021-2026) Table 56. Global Anti-Infective Vaccines Price by Application (2021-2026) & (US$/unit) Table 57. Global Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 58. Global Anti-Infective Vaccines Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anti-Infective Vaccines Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anti-Infective Vaccines Sales Market Share in Value by Application (2027-2032) Table 61. Global Anti-Infective Vaccines Price by Application (2027-2032) & (US$/unit) Table 62. North America Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 63. North America Anti-Infective Vaccines Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 65. Europe Anti-Infective Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Anti-Infective Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 69. Latin America Anti-Infective Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Anti-Infective Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Pasteur Company Information Table 73. Sanofi Pasteur Business Overview Table 74. Sanofi Pasteur Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Sanofi Pasteur Anti-Infective Vaccines Product Portfolio Table 76. Sanofi Pasteur Recent Development Table 77. Novartis Vaccines Company Information Table 78. Novartis Vaccines Business Overview Table 79. Novartis Vaccines Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Novartis Vaccines Anti-Infective Vaccines Product Portfolio Table 81. Novartis Vaccines Recent Development Table 82. Merck & Co. Company Information Table 83. Merck & Co. Business Overview Table 84. Merck & Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Merck & Co. Anti-Infective Vaccines Product Portfolio Table 86. Merck & Co. Recent Development Table 87. GlaxoSmithKline Biologicals Company Information Table 88. GlaxoSmithKline Biologicals Business Overview Table 89. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio Table 91. GlaxoSmithKline Biologicals Recent Development Table 92. Wyeth Pharmaceuticals, Inc. Company Information Table 93. Wyeth Pharmaceuticals, Inc. Business Overview Table 94. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio Table 96. Wyeth Pharmaceuticals, Inc. Recent Development Table 97. Protein Sciences Co. Company Information Table 98. Protein Sciences Co. Business Overview Table 99. Protein Sciences Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Protein Sciences Co. Anti-Infective Vaccines Product Portfolio Table 101. Protein Sciences Co. Recent Development Table 102. Organon Teknika Co. Company Information Table 103. Organon Teknika Co. Business Overview Table 104. Organon Teknika Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Organon Teknika Co. Anti-Infective Vaccines Product Portfolio Table 106. Organon Teknika Co. Recent Development Table 107. MedImmune LLC Company Information Table 108. MedImmune LLC Business Overview Table 109. MedImmune LLC Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. MedImmune LLC Anti-Infective Vaccines Product Portfolio Table 111. MedImmune LLC Recent Development Table 112. MassBiologics Company Information Table 113. MassBiologics Business Overview Table 114. MassBiologics Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. MassBiologics Anti-Infective Vaccines Product Portfolio Table 116. MassBiologics Recent Development Table 117. Intercell Biomedical Company Information Table 118. Intercell Biomedical Business Overview Table 119. Intercell Biomedical Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Intercell Biomedical Anti-Infective Vaccines Product Portfolio Table 121. Intercell Biomedical Recent Development Table 122. ID Biomedical Co. Company Information Table 123. ID Biomedical Co. Business Overview Table 124. ID Biomedical Co. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. ID Biomedical Co. Anti-Infective Vaccines Product Portfolio Table 126. ID Biomedical Co. Recent Development Table 127. Emergent BioDefense Operations Lansing Inc. Company Information Table 128. Emergent BioDefense Operations Lansing Inc. Business Overview Table 129. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio Table 131. Emergent BioDefense Operations Lansing Inc. Recent Development Table 132. Diagnostics Ltd. Company Information Table 133. Diagnostics Ltd. Business Overview Table 134. Diagnostics Ltd. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio Table 136. Diagnostics Ltd. Recent Development Table 137. CSL Ltd. Company Information Table 138. CSL Ltd. Business Overview Table 139. CSL Ltd. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. CSL Ltd. Anti-Infective Vaccines Product Portfolio Table 141. CSL Ltd. Recent Development Table 142. Berna Biotech Company Information Table 143. Berna Biotech Business Overview Table 144. Berna Biotech Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Berna Biotech Anti-Infective Vaccines Product Portfolio Table 146. Berna Biotech Recent Development Table 147. Barr Labs, Inc. Company Information Table 148. Barr Labs, Inc. Business Overview Table 149. Barr Labs, Inc. Anti-Infective Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio Table 151. Barr Labs, Inc. Recent Development Table 152. North America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. North America Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 154. North America Anti-Infective Vaccines Sales Market Share by Country (2021-2026) Table 155. North America Anti-Infective Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 156. North America Anti-Infective Vaccines Sales Market Share Forecast by Country (2027-2032) Table 157. North America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America Anti-Infective Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 159. North America Anti-Infective Vaccines Market Share by Country (2021-2026) Table 160. North America Anti-Infective Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America Anti-Infective Vaccines Market Share Forecast by Country (2027-2032) Table 162. Europe Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Europe Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 164. Europe Anti-Infective Vaccines Sales Market Share by Country (2021-2026) Table 165. Europe Anti-Infective Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 166. Europe Anti-Infective Vaccines Sales Market Share Forecast by Country (2027-2032) Table 167. Europe Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe Anti-Infective Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe Anti-Infective Vaccines Market Share by Country (2021-2026) Table 170. Europe Anti-Infective Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe Anti-Infective Vaccines Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 174. Asia-Pacific Anti-Infective Vaccines Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific Anti-Infective Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 176. Asia-Pacific Anti-Infective Vaccines Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Anti-Infective Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific Anti-Infective Vaccines Market Share by Country (2021-2026) Table 180. Asia-Pacific Anti-Infective Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific Anti-Infective Vaccines Market Share Forecast by Country (2027-2032) Table 182. Latin America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Latin America Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 184. Latin America Anti-Infective Vaccines Sales Market Share by Country (2021-2026) Table 185. Latin America Anti-Infective Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 186. Latin America Anti-Infective Vaccines Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America Anti-Infective Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America Anti-Infective Vaccines Market Share by Country (2021-2026) Table 190. Latin America Anti-Infective Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America Anti-Infective Vaccines Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 194. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa Anti-Infective Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 196. Middle East and Africa Anti-Infective Vaccines Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Anti-Infective Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa Anti-Infective Vaccines Market Share by Country (2021-2026) Table 200. Middle East and Africa Anti-Infective Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa Anti-Infective Vaccines Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Anti-Infective Vaccines Distributors List Table 205. Anti-Infective Vaccines Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Anti-Infective Vaccines Image Figure 2. Global Anti-Infective Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Infective Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Infective Vaccines Sales (2021-2032) & (k units) Figure 5. Inactivated Vaccines Image Figure 6. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Live/attenuated Vaccines Image Figure 8. Global Live/attenuated Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Conjugate Vaccines Image Figure 10. Global Conjugate Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Anti-Infective Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anti-Infective Vaccines Market Share by Type 2025 VS 2032 Figure 13. North America Anti-Infective Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. North America Anti-Infective Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Europe Anti-Infective Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anti-Infective Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anti-Infective Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anti-Infective Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anti-Infective Vaccines Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Bacterial Diseases Image Figure 26. Global Bacterial Diseases Sales YoY Growth (2021-2032) & (k units) Figure 27. Viral Diseases Image Figure 28. Global Viral Diseases Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Anti-Infective Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Anti-Infective Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Anti-Infective Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Anti-Infective Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Anti-Infective Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Anti-Infective Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Anti-Infective Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Anti-Infective Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Anti-Infective Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Anti-Infective Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Anti-Infective Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Anti-Infective Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Anti-Infective Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Anti-Infective Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-Infective Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Anti-Infective Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anti-Infective Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Anti-Infective Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-Infective Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Anti-Infective Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anti-Infective Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Anti-Infective Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-Infective Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Anti-Infective Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anti-Infective Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anti-Infective Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-Infective Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Anti-Infective Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anti-Infective Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Anti-Infective Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Anti-Infective Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Anti-Infective Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccines
  • Live/attenuated Vaccines
  • Conjugate Vaccines
Applications
  • Bacterial Diseases
  • Viral Diseases
Companies covered
  • Sanofi Pasteur
  • Novartis Vaccines
  • Merck & Co.
  • GlaxoSmithKline Biologicals
  • Wyeth Pharmaceuticals, Inc.
  • Protein Sciences Co.
  • Organon Teknika Co.
  • MedImmune LLC
  • MassBiologics
  • Intercell Biomedical
  • ID Biomedical Co.
  • Emergent BioDefense Operations Lansing Inc.
  • Diagnostics Ltd.
  • CSL Ltd.
  • Berna Biotech
  • Barr Labs, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Infective Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Infective Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Infective Vaccines Market by Type
  6. 1.3.1 Inactivated Vaccines
  7. 1.3.2 Live/attenuated Vaccines
  8. 1.3.3 Conjugate Vaccines
  9. 1.4 Global Anti-Infective Vaccines Market Size by Type
  10. 1.4.1 Global Anti-Infective Vaccines Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anti-Infective Vaccines Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anti-Infective Vaccines Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anti-Infective Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anti-Infective Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anti-Infective Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anti-Infective Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anti-Infective Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Infective Vaccines Industry Trends
  2. 2.2 Anti-Infective Vaccines Industry Drivers
  3. 2.3 Anti-Infective Vaccines Industry Opportunities and Challenges
  4. 2.4 Anti-Infective Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Infective Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Infective Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Infective Vaccines Price (2021-2026)
  4. 3.4 Global Anti-Infective Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Infective Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Infective Vaccines Company, Product Type & Application
  7. 3.7 Global Anti-Infective Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Infective Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Infective Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Infective Vaccines Tier 1, Tier 2, and Tier 3
4 Anti-Infective Vaccines Regional Status and Outlook
  1. 4.1 Global Anti-Infective Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Infective Vaccines Historic Market Size by Region
  3. 4.2.1 Global Anti-Infective Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Infective Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Infective Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Infective Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Infective Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Infective Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Infective Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Infective Vaccines by Application
  1. 5.1 Anti-Infective Vaccines Market by Application
  2. 5.1.1 Bacterial Diseases
  3. 5.1.2 Viral Diseases
  4. 5.2 Global Anti-Infective Vaccines Market Size by Application
  5. 5.2.1 Global Anti-Infective Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-Infective Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-Infective Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-Infective Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-Infective Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-Infective Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-Infective Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-Infective Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi Pasteur
  2. 6.1.1 Sanofi Pasteur Company Information
  3. 6.1.2 Sanofi Pasteur Business Overview
  4. 6.1.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pasteur Anti-Infective Vaccines Product Portfolio
  6. 6.1.5 Sanofi Pasteur Recent Developments
  7. 6.2 Novartis Vaccines
  8. 6.2.1 Novartis Vaccines Company Information
  9. 6.2.2 Novartis Vaccines Business Overview
  10. 6.2.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Vaccines Anti-Infective Vaccines Product Portfolio
  12. 6.2.5 Novartis Vaccines Recent Developments
  13. 6.3 Merck & Co.
  14. 6.3.1 Merck & Co. Company Information
  15. 6.3.2 Merck & Co. Business Overview
  16. 6.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co. Anti-Infective Vaccines Product Portfolio
  18. 6.3.5 Merck & Co. Recent Developments
  19. 6.4 GlaxoSmithKline Biologicals
  20. 6.4.1 GlaxoSmithKline Biologicals Company Information
  21. 6.4.2 GlaxoSmithKline Biologicals Business Overview
  22. 6.4.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio
  24. 6.4.5 GlaxoSmithKline Biologicals Recent Developments
  25. 6.5 Wyeth Pharmaceuticals, Inc.
  26. 6.5.1 Wyeth Pharmaceuticals, Inc. Company Information
  27. 6.5.2 Wyeth Pharmaceuticals, Inc. Business Overview
  28. 6.5.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio
  30. 6.5.5 Wyeth Pharmaceuticals, Inc. Recent Developments
  31. 6.6 Protein Sciences Co.
  32. 6.6.1 Protein Sciences Co. Company Information
  33. 6.6.2 Protein Sciences Co. Business Overview
  34. 6.6.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Protein Sciences Co. Anti-Infective Vaccines Product Portfolio
  36. 6.6.5 Protein Sciences Co. Recent Developments
  37. 6.7 Organon Teknika Co.
  38. 6.7.1 Organon Teknika Co. Company Information
  39. 6.7.2 Organon Teknika Co. Business Overview
  40. 6.7.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Organon Teknika Co. Anti-Infective Vaccines Product Portfolio
  42. 6.7.5 Organon Teknika Co. Recent Developments
  43. 6.8 MedImmune LLC
  44. 6.8.1 MedImmune LLC Company Information
  45. 6.8.2 MedImmune LLC Business Overview
  46. 6.8.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MedImmune LLC Anti-Infective Vaccines Product Portfolio
  48. 6.8.5 MedImmune LLC Recent Developments
  49. 6.9 MassBiologics
  50. 6.9.1 MassBiologics Company Information
  51. 6.9.2 MassBiologics Business Overview
  52. 6.9.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 MassBiologics Anti-Infective Vaccines Product Portfolio
  54. 6.9.5 MassBiologics Recent Developments
  55. 6.10 Intercell Biomedical
  56. 6.10.1 Intercell Biomedical Company Information
  57. 6.10.2 Intercell Biomedical Business Overview
  58. 6.10.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Intercell Biomedical Anti-Infective Vaccines Product Portfolio
  60. 6.10.5 Intercell Biomedical Recent Developments
  61. 6.11 ID Biomedical Co.
  62. 6.11.1 ID Biomedical Co. Company Information
  63. 6.11.2 ID Biomedical Co. Business Overview
  64. 6.11.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ID Biomedical Co. Anti-Infective Vaccines Product Portfolio
  66. 6.11.5 ID Biomedical Co. Recent Developments
  67. 6.12 Emergent BioDefense Operations Lansing Inc.
  68. 6.12.1 Emergent BioDefense Operations Lansing Inc. Company Information
  69. 6.12.2 Emergent BioDefense Operations Lansing Inc. Business Overview
  70. 6.12.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio
  72. 6.12.5 Emergent BioDefense Operations Lansing Inc. Recent Developments
  73. 6.13 Diagnostics Ltd.
  74. 6.13.1 Diagnostics Ltd. Company Information
  75. 6.13.2 Diagnostics Ltd. Business Overview
  76. 6.13.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio
  78. 6.13.5 Diagnostics Ltd. Recent Developments
  79. 6.14 CSL Ltd.
  80. 6.14.1 CSL Ltd. Company Information
  81. 6.14.2 CSL Ltd. Business Overview
  82. 6.14.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CSL Ltd. Anti-Infective Vaccines Product Portfolio
  84. 6.14.5 CSL Ltd. Recent Developments
  85. 6.15 Berna Biotech
  86. 6.15.1 Berna Biotech Company Information
  87. 6.15.2 Berna Biotech Business Overview
  88. 6.15.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Berna Biotech Anti-Infective Vaccines Product Portfolio
  90. 6.15.5 Berna Biotech Recent Developments
  91. 6.16 Barr Labs, Inc.
  92. 6.16.1 Barr Labs, Inc. Company Information
  93. 6.16.2 Barr Labs, Inc. Business Overview
  94. 6.16.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio
  96. 6.16.5 Barr Labs, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Infective Vaccines Sales by Country
  2. 7.1.1 North America Anti-Infective Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Infective Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Infective Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Infective Vaccines Market Size by Country
  6. 7.2.1 North America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Infective Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Infective Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Infective Vaccines Sales by Country
  2. 8.1.1 Europe Anti-Infective Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Infective Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Infective Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Infective Vaccines Market Size by Country
  6. 8.2.1 Europe Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Infective Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Infective Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Infective Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Infective Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Infective Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Infective Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Infective Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Infective Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Infective Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Infective Vaccines Sales by Country
  2. 10.1.1 South America Anti-Infective Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Infective Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Infective Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Infective Vaccines Market Size by Country
  6. 10.2.1 South America Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Infective Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Infective Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Infective Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Infective Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Infective Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Infective Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Infective Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Infective Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Infective Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Infective Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Infective Vaccines Value Chain Analysis
  2. 12.1.1 Anti-Infective Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Infective Vaccines Production Mode & Process
  7. 12.2 Anti-Infective Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Infective Vaccines Distributors
  10. 12.2.3 Anti-Infective Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst